News

The women – all current or former employees – are seeking $250 million in damages for claims that the drug maker allowed discriminatory and disparate pay and promotion policies and had a hostile work environment – referred to as...

British drug maker GlaxoSmithKline (GSK) has signed an agreement with Aspen Global (AGI) to acquire interest in its newly established subsidiary Aspen Japan. As part of the deal, GSK will acquire a 25%...

Japan-based Daiichi Sankyo has signed an agreement to acquire US-based Ambit Biosciences, for about $410m. As part of the deal, Daiichi will pay $15 per share in cash to Ambit through a tender offer,...

Cipla Medpro subsidiary Medpro Pharmaceutica has entered into an agreement with Teva Pharmaceuticals. As part of the deal, Medpro will exclusively market Teva's pharmaceutical product portfolio in South Africa. Cipla Medpro CEO Paul Miller said:...

Austria-based Nabriva Therapeutics has received qualified infectious disease product (QIDP) and fast-track status designation from the US Food and Drug Administration for its lefamulin (BC 3781). The designation has been granted for lefamulin...

US-based Pfizer has introduced a new scratch card in a bid to involve the public in medicines optimisation. The card has been designed to increase patient engagement with the pharmacy team and create opportunities to...

US-based Johnson & Johnson has signed an agreement to acquire a privately held clinical stage biopharmaceutical company, Alios BioPharma, for $1.75bn in cash. Based in California, US, Alios develops therapies for the treatment of...